ramatroban has been researched along with thromboxane a2 in 38 studies
Studies (ramatroban) | Trials (ramatroban) | Recent Studies (post-2010) (ramatroban) | Studies (thromboxane a2) | Trials (thromboxane a2) | Recent Studies (post-2010) (thromboxane a2) |
---|---|---|---|---|---|
142 | 10 | 28 | 5,617 | 224 | 429 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (7.89) | 18.7374 |
1990's | 27 (71.05) | 18.2507 |
2000's | 7 (18.42) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (2.63) | 2.80 |
Authors | Studies |
---|---|
Darius, H; Meyer, J; Michael-Hepp, J | 1 |
Dellweg, H; Gross, R; Perzborn, E; Theis, JG | 2 |
Francis, HP; Gardiner, PJ; Greenham, SJ; Patel, UP; Thompson, AM | 1 |
Fiedler, VB; Perzborn, E; Seuter, F | 1 |
Karasawa, A; Lefer, AM; Ma, XL | 1 |
Braun, M; Schrör, K | 1 |
Böshagen, H; Fiedler, VB; Perzborn, E; Rosentreter, U; Seuter, F | 3 |
Aizawa, H; Hara, N; Inoue, H; Koto, H; Matsumoto, K; Shigyo, M; Takata, S | 2 |
Arima, M; Fukuda, T; Makino, S; Yukawa, T | 1 |
Altavilla, D; Campo, GM; Canale, P; Caputi, AP; Ioculano, M; Sardella, A; Squadrito, F; Squadrito, G; Urna, G | 1 |
Itoh, Y | 1 |
Badenhorst, PN; Hundt, HK; Lötter, MG; Nel, CJ; Pieters, H; Roodt, JP; Schall, R; van Wyk, V | 1 |
Altavilla, D; Campo, GM; Canale, P; Caputi, AP; Faggiotto, A; Ioculano, M; Oriti, S; Saitta, A; Squadrito, F; Zingarelli, B | 1 |
Igarashi, A; Iijima, H; Inoue, H; Okada, S; Takishima, T; Tani, N | 1 |
Lucchesi, BR; Mu, DX; Rote, WE | 1 |
Inagaki, N; Matsuo, A; Nagai, H; Takeda, H; Tanaka, H; Yamaguchi, S | 1 |
Gundel, R; Jesmok, G | 1 |
Fujimura, M; Kasahara, K; Matsuda, T; Nakatsumi, Y; Nishi, K | 1 |
Akiyama, K; Endo, S | 1 |
Aizawa, H; Hara, N; Inoue, H; Koto, H; Matsumoto, K; Nakano, H | 1 |
Mazar-Feldman, J; Rimon, G | 1 |
Cui, ZH; Kawikova, I; Lötvall, J; Okazawa, A; Skoogh, BE | 1 |
Ahr, HJ; Beckermann, B; Boberg, M; Bühner, K; Hirayama, M; Siefert, HM; Steinke, W; Wünsche, C | 1 |
Ahr, HJ; Hirayama, M; Steinke, W | 1 |
Abbas, F; Amin, Z; Burk, RM; Krauss, AH; Marshall, K; Senior, J; Woodward, DF | 1 |
Diener, M; Schultheiss, G | 1 |
Diener, M; Frings, M; Haschke, G; Heinke, B; Schäfer, KH | 1 |
Fujisawa, C; Hironaka, T; Itakura, A; Kawamoto, K; Matsuda, H; Mitsuhashi, M; Sawada, S; Takaku, M; Tanaka, A | 1 |
Kamei, C; Kayasuga, R; Sugimoto, Y; Watanabe, T | 1 |
Benoit, P; de Leval, X; Delarge, J; Dogné, JM; Masereel, B | 1 |
Moriwaki, T; Yamamoto, A; Yasui, H | 1 |
Dogné, JM; Masereel, B; Rolin, S | 1 |
Jiang, S; Kamei, C; Kishi, Y; Nakano, Y; Yatsuzuka, R | 1 |
Abdelazeem, H; Aljesri, K; Norel, X; Ozen, G; Topal, G; Turkyılmaz, G; Turkyılmaz, S | 1 |
3 review(s) available for ramatroban and thromboxane a2
Article | Year |
---|---|
[Thromboxane A2 receptor antagonist in asthma therapy].
Topics: Asthma; Benzoquinones; Bridged Bicyclo Compounds; Bronchi; Bronchial Hyperreactivity; Carbazoles; Fatty Acids, Monounsaturated; Heptanoic Acids; Humans; Prostaglandins; Receptors, Thromboxane; Sulfonamides; Thromboxane A2 | 1996 |
Thromboxane A2 inhibition: therapeutic potential in bronchial asthma.
Topics: Anti-Asthmatic Agents; Asthma; Benzoquinones; Carbazoles; Heptanoic Acids; Humans; Methacrylates; Molecular Structure; Receptors, Thromboxane; Sulfonamides; Thromboxane A2; Thromboxane-A Synthase | 2002 |
Prostanoids as pharmacological targets in COPD and asthma.
Topics: Animals; Asthma; Benzoquinones; Carbazoles; Enzyme Inhibitors; F2-Isoprostanes; Heptanoic Acids; Humans; Methacrylates; Prostaglandin Antagonists; Prostaglandin D2; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Receptors, Immunologic; Receptors, Prostaglandin; Receptors, Thromboxane A2, Prostaglandin H2; Sulfonamides; Thromboxane A2; Thromboxane-A Synthase | 2006 |
2 trial(s) available for ramatroban and thromboxane a2
Article | Year |
---|---|
Antithrombotic activity of Bay u3405, a thromboxane A2-antagonist, in patients with Dacron aortic grafts: a random controlled clinical trial.
Topics: Aged; Aorta; Blood Platelets; Blood Vessel Prosthesis; Carbazoles; Cell Survival; Double-Blind Method; Follow-Up Studies; Humans; Indium Radioisotopes; Male; Middle Aged; Platelet Adhesiveness; Polyethylene Terephthalates; Sulfonamides; Thromboxane A2 | 1993 |
Involvement of thromboxane A2 in bronchial hyperresponsiveness of asthma. Kanazawa Asthma Research Group.
Topics: Adolescent; Adult; Airway Resistance; Asthma; Bridged Bicyclo Compounds; Bronchial Hyperreactivity; Bronchoconstrictor Agents; Carbazoles; Cross-Over Studies; Double-Blind Method; Fatty Acids, Monounsaturated; Female; Forced Expiratory Volume; Humans; Male; Methacholine Chloride; Middle Aged; Prostaglandin Antagonists; Sulfonamides; Thromboxane A2 | 1995 |
33 other study(ies) available for ramatroban and thromboxane a2
Article | Year |
---|---|
Receptor binding properties of the new and specific thromboxane receptor antagonist Bay U 3405.
Topics: Binding, Competitive; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Carbazoles; Fatty Acids, Unsaturated; Humans; Hydrazines; In Vitro Techniques; Kinetics; Membranes; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxane A2; Thromboxanes | 1992 |
pH-dependent binding of the TXA2/PGH2-receptor of human platelet membranes to various ligands.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Blood Platelets; Carbazoles; Cell Membrane; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Kinetics; Ligands; Phenylacetates; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxane A2; Thromboxanes; Vasoconstrictor Agents | 1992 |
Binding characteristics of the new thromboxane A2/prostaglandin H2 receptor antagonist [3H]BAY U 3405 to washed human platelets and platelet membranes.
Topics: Blood Platelets; Carbazoles; Cell Fractionation; Cell Membrane; Humans; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxane A2 | 1992 |
BAY u3405 an antagonist of thromboxane A2- and prostaglandin D2-induced bronchoconstriction in the guinea-pig.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Administration, Oral; Aerosols; Animals; Blood Pressure; Bronchoconstriction; Carbazoles; Guinea Pigs; Histamine; In Vitro Techniques; Injections, Intravenous; Male; Prostaglandin D2; Prostaglandin Endoperoxides, Synthetic; Serotonin; SRS-A; Sulfonamides; Thromboxane A2; Thromboxanes | 1991 |
Effect of BAY U 3405, a new thromboxane antagonist, on arachidonic acid induced thromboembolism.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Bronchoconstriction; Carbazoles; Death, Sudden; Dose-Response Relationship, Drug; Male; Platelet Aggregation; Rabbits; Sulfonamides; Survival Rate; Thromboembolism; Thromboxane A2; Thromboxanes | 1991 |
Mechanism of the protective action of Bay-u-3405, a new specific thromboxane receptor antagonist, in arachidonate-induced sudden death.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Blood Pressure; Bronchi; Carbazoles; Death, Sudden; Electrocardiography; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Radioimmunoassay; Sulfonamides; Thromboxane A2; Thromboxanes | 1991 |
Bay U 3405 inhibits cerebral vasospasm induced by authentic thromboxane A2.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Blood Platelets; Carbazoles; Cattle; Cerebral Arteries; Humans; Ischemic Attack, Transient; Prostaglandin Endoperoxides, Synthetic; Serotonin; Sulfonamides; Thromboxane A2; Thromboxanes; Vasoconstriction | 1990 |
Synthesis and absolute configuration of the new thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9-carbazolepropan oic acid and comparison with its enantiomer.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Carbazoles; Chemical Phenomena; Chemistry; Humans; In Vitro Techniques; Molecular Conformation; Muscle Contraction; Muscle, Smooth, Vascular; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Rabbits; Stereoisomerism; Sulfonamides; Thromboxane A2 | 1989 |
Inhibition of platelet aggregation in vitro and ex vivo by the new thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9- carbazolepropanoic acid.
Topics: Animals; Carbazoles; Collagen; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Inbred Strains; Sulfonamides; Thromboxane A2 | 1989 |
Reduction of in vivo coronary artery thrombosis by the novel thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9- carbazolepropanoic acid.
Topics: Animals; Blood Pressure; Carbazoles; Coronary Circulation; Coronary Disease; Coronary Thrombosis; Dogs; Electric Stimulation; Female; Fibrinolytic Agents; Heart Rate; Humans; In Vitro Techniques; Male; Myocardial Infarction; Sulfonamides; Thromboxane A2 | 1989 |
Effect of BAY u3405, a thromboxane A2 receptor antagonist, on neuro-effector transmission in canine tracheal tissue.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Atropine; Carbazoles; Dogs; Electric Stimulation; Female; Male; Muscle Contraction; Muscle, Smooth; Prostaglandin Endoperoxides, Synthetic; Receptors, Thromboxane; Sulfonamides; Synaptic Transmission; Tetrodotoxin; Thromboxane A2; Trachea; Vagus Nerve; Vasoconstrictor Agents | 1995 |
[Effect of BAY u3405-thromboxane A2 receptor antagonist, on biphasic airway responses induced by platelet-activating factor in actively sensitized guinea pigs].
Topics: Airway Resistance; Animals; Carbazoles; Guinea Pigs; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Receptors, Thromboxane; Sulfonamides; Thromboxane A2; Vaccination | 1995 |
Beneficial effects of BAY u3405, a novel thromboxane A2 receptor antagonist, in splanchnic artery occlusion shock.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arterial Occlusive Diseases; Blood Pressure; Carbazoles; Macrophages; Male; Myocardial Depressant Factor; Peroxidase; Phagocytosis; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Shock; Splanchnic Circulation; Sulfonamides; Survival Rate; Thromboxane A2; Thromboxane B2 | 1994 |
Blockade of thromboxane A2 receptor ameliorates delayed postischemic hypoperfusion of the brain in cats.
Topics: Animals; Carbazoles; Cats; Cerebrovascular Circulation; Ischemic Attack, Transient; Perfusion; Reaction Time; Receptors, Thromboxane; Sulfonamides; Thromboxane A2 | 1994 |
Reduction of myocardial leukocyte accumulation and myocardial infarct size following administration of BAY u3405, a thromboxane A2 receptor antagonist, in myocardial ischaemia-reperfusion injury.
Topics: Animals; Carbazoles; Creatine Kinase; Hemodynamics; Leukocytes; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Peroxidase; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Sulfonamides; Thromboxane A2 | 1993 |
[Effect of thromboxane receptor antagonist, BAY u 3405 on the late phase pulmonary response in guinea pigs].
Topics: Airway Resistance; Animals; Asthma; Bronchoalveolar Lavage Fluid; Carbazoles; Guinea Pigs; Leukocyte Count; Lung; Male; Receptors, Thromboxane; Sulfonamides; Thromboxane A2 | 1993 |
Thromboxane antagonism in experimental canine carotid artery thrombosis.
Topics: Animals; Carbazoles; Carotid Artery Thrombosis; Disease Models, Animal; Dogs; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Sulfonamides; Thromboxane A2 | 1993 |
The effect of a thromboxane A2 receptor antagonist BAY-u-3405 on experimental allergic reactions.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Bronchial Hyperreactivity; Carbazoles; Dermatitis; Guinea Pigs; Hypersensitivity; Immunoglobulin E; Male; Mice; Mice, Inbred BALB C; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Receptors, Thromboxane; Sulfonamides; Thromboxane A2 | 1995 |
Thromboxane-blocked swine as an experimental model of severe intravascular inflammation and septic shock.
Topics: Animals; Antibodies, Monoclonal; Bronchoconstriction; Capillary Permeability; Carbazoles; Disease Models, Animal; Dose-Response Relationship, Drug; Escherichia coli; Inflammation; Leukocytes; Leukopenia; Lung; Platelet Aggregation Inhibitors; Pulmonary Circulation; Receptors, Thromboxane; Shock, Septic; Sulfonamides; Swine; Thromboxane A2; Tumor Necrosis Factor-alpha; Vasoconstriction | 1995 |
Thromboxane A2 mimetic (U-46619) induces hyperresponsiveness of smooth muscle in the canine bronchiole, but not in the trachea.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Bronchi; Carbazoles; Dogs; Female; Male; Muscle Contraction; Muscle, Smooth; Prostaglandin Endoperoxides, Synthetic; Receptors, Thromboxane; Sulfonamides; Thromboxane A2; Trachea; Vasoconstrictor Agents | 1996 |
Thromboxane A2 antagonist inhibits leukotriene D4-induced smooth muscle contraction in guinea-pig lung parenchyma, but not in trachea.
Topics: Animals; Carbazoles; Female; Guinea Pigs; Leukotriene D4; Lung; Male; Muscle Contraction; Muscle, Smooth; Platelet Aggregation Inhibitors; Sulfonamides; Thromboxane A2; Trachea | 1996 |
A common low-affinity binding site for primary prostanoids on bovine aortic endothelial cells.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aorta; Binding Sites; Biphenyl Compounds; Carbazoles; Cattle; Cells, Cultured; Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide; Dinoprostone; Endothelium, Vascular; Epoprostenol; Heptanoic Acids; Iloprost; Prostaglandin Endoperoxides, Synthetic; Prostaglandins; Sulfonamides; Thromboxane A2; Thromboxanes; Xanthenes; Xanthones | 1996 |
8-Epi-PGF2alpha induces airflow obstruction and airway plasma exudation in vivo.
Topics: Airway Obstruction; Animals; Bronchoalveolar Lavage Fluid; Carbazoles; Dinoprost; Guinea Pigs; Histamine Antagonists; Male; Methacrylates; Platelet Aggregation Inhibitors; Sulfonamides; Thromboxane A2; Thromboxane B2; Vasoconstrictor Agents | 1997 |
Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
Topics: Administration, Oral; Animals; Biological Availability; Biotransformation; Carbazoles; Chromatography, High Pressure Liquid; Dogs; Enterohepatic Circulation; Female; In Vitro Techniques; Injections, Intravenous; Intestinal Absorption; Liver; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Rats; Rats, Wistar; Receptors, Thromboxane; Sex Characteristics; Species Specificity; Spectrophotometry, Ultraviolet; Sulfonamides; Thromboxane A2 | 1997 |
Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 2nd communication: distribution to organs and tissues in male, female and pregnant rats, and characteristics of protein binding in plasma.
Topics: Administration, Oral; Animals; Area Under Curve; Autoradiography; Blood Proteins; Carbazoles; Dogs; Female; Injections, Intravenous; Male; Mice; Milk; Placenta; Pregnancy; Protein Binding; Rabbits; Rats; Rats, Wistar; Receptors, Thromboxane; Sulfonamides; Thromboxane A2; Tissue Distribution | 1997 |
A comparative study of thromboxane (TP) receptor mimetics and antagonists on isolated human umbilical artery and myometrium.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Bridged Bicyclo Compounds, Heterocyclic; Carbazoles; Fatty Acids, Unsaturated; Female; Humans; Hydrazines; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Muscle, Smooth, Vascular; Myometrium; Receptors, Thromboxane; Sulfonamides; Thromboxane A2; Umbilical Arteries | 1997 |
Inhibition of spontaneous smooth muscle contractions in rat and rabbit intestine by blockers of the thromboxane A2 pathway.
Topics: Animals; Benzimidazoles; Benzoxepins; Carbachol; Carbazoles; Colon; Female; In Vitro Techniques; Indomethacin; Intestine, Small; Isometric Contraction; Male; Masoprocol; Muscle, Smooth; Rabbits; Rats; Rats, Wistar; Receptors, Thromboxane; Sulfonamides; Thromboxane A2 | 1999 |
Spontaneous contractions of intestinal smooth muscle re-aggregates from the new-born rat triggered by thromboxane A2.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Animals, Newborn; Calcium; Carbachol; Carbazoles; Cell Aggregation; Cholinergic Agonists; Fluorescent Dyes; Fura-2; Intestine, Small; Microscopy, Fluorescence; Muscle Contraction; Muscle, Smooth; Platelet Aggregation Inhibitors; Rats; Sulfonamides; Tetrodotoxin; Thromboxane A2; Vasoconstrictor Agents; Verapamil | 2000 |
Necessity of thromboxane A2 for initiation of platelet-mediated contact sensitivity: dual activation of platelets and vascular endothelial cells.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Triphosphate; Animals; Aorta, Abdominal; Aorta, Thoracic; Blood Platelets; Carbazoles; Cells, Cultured; Dermatitis, Contact; Ear; Endothelium, Vascular; Humans; Immune Sera; Injections, Intradermal; Injections, Intraperitoneal; Injections, Intravenous; Intercellular Adhesion Molecule-1; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Platelet Activation; Platelet Aggregation Inhibitors; Receptors, Thromboxane; Serotonin; Sulfonamides; Thromboxane A2; Vascular Cell Adhesion Molecule-1; Vasoconstrictor Agents | 2001 |
Participation of chemical mediators other than histamine in nasal allergy signs: a study using mice lacking histamine H(1) receptors.
Topics: Animals; Anti-Allergic Agents; Antigens; Behavior, Animal; Carbazoles; Cetirizine; Dose-Response Relationship, Drug; Female; Histamine H1 Antagonists; Immunization; Immunoglobulin E; Indicators and Reagents; Indoles; Leukotriene Antagonists; Mice; Mice, Knockout; Ovalbumin; Passive Cutaneous Anaphylaxis; Phenylcarbamates; Receptors, Histamine H1; Rhinitis, Allergic, Seasonal; Sneezing; Sulfonamides; Thromboxane A2; Tosyl Compounds | 2002 |
Pharmacokinetic analysis of ramatroban using a recirculatory model with enterohepatic circulation by measuring portal and systemic blood concentration difference in Sprague-Dawley and Eisai hyperbilirubinemic rats.
Topics: Administration, Oral; Animals; Animals, Genetically Modified; Bile; Carbazoles; Disease Models, Animal; Enterohepatic Circulation; Glucuronides; Hyperbilirubinemia; Injections, Intravenous; Membrane Transport Proteins; Metabolic Clearance Rate; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane A2, Prostaglandin H2; Species Specificity; Sulfonamides; Thromboxane A2 | 2004 |
Participation in cysteinyl leukotrienes and thromboxane A2 in nasal congestion model in Brown Norway rats.
Topics: Animals; Benzoquinones; Carbazoles; Chromones; Dose-Response Relationship, Drug; Heptanoic Acids; Indoles; Leukotrienes; Male; Membrane Proteins; Phenylcarbamates; Rats; Rats, Inbred BN; Receptors, Leukotriene; Receptors, Thromboxane A2, Prostaglandin H2; Rhinitis; Sneezing; Sulfonamides; Thromboxane A2; Tosyl Compounds | 2007 |
Comparative study on the effect of aspirin, TP receptor antagonist and TxA
Topics: Arachidonic Acid; Aspirin; Benzofurans; Carbazoles; Enzyme Inhibitors; Female; Humans; Male; Mammary Arteries; Muscle, Smooth, Vascular; Phenylephrine; Receptors, Prostaglandin; Receptors, Thromboxane; Saphenous Vein; Sulfonamides; Thromboxane A2; Thromboxane-A Synthase; Thromboxanes; Vasoconstriction | 2021 |